v3.26.3
Earnings (Loss) Per Share (Tables)
 9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Income (Loss) Per Share
The following tables set forth the computation of basic and diluted net income (loss) per share of common stock:
Three Months Ended September 30,
(in millions, except shares and per share amounts)
20262025
Basic net income per share attributable to common stockholders
Numerator:
Net income$2.2 $38.7 
Denominator:
Weighted average number of shares of common stock outstanding291,557,934 316,966,947 
Basic net income per share attributable to common stockholders$0.01 $0.12 
Diluted net income per share attributable to common stockholders
Numerator:
Net income$2.2 $38.7 
Denominator:
Number of shares used in basic computation291,557,934 316,966,947 
Add: weighted-average effect of dilutive securities exchangeable for common stock:
Liability-classified awards1,348,862 — 
Weighted average shares of common stock outstanding used to calculate diluted net income per share292,906,796 316,966,947 
Diluted net income per share attributable to common stockholders$0.01 $0.12 
Nine Months Ended September 30,
(in millions, except shares and per share amounts)
20262025
Basic net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(612.2)$89.5 
Denominator:
Weighted average number of shares of common stock outstanding296,170,958 328,317,197 
Basic net income (loss) per share attributable to common stockholders$(2.07)$0.27 
Diluted net income (loss) per share attributable to common stockholders
Numerator:
Net income (loss)$(612.2)$89.5 
Denominator:
Weighted average shares of common stock outstanding used to calculate diluted net income (loss) per share296,170,958 328,317,197 
Diluted net income (loss) per share attributable to common stockholders$(2.07)$0.27 
Schedule of Potential Common Stock Equivalents Excluded from Calculation of Diluted Net Income (Loss) Per Share Potentially dilutive securities excluded due to their anti-dilutive effect were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Restricted stock units27,069,483 16,409,811 21,190,922 15,776,487 
ESPP Shares1,294,100 — 1,294,100 — 
CEO Premium-Priced Performance Option9,678,000 — 9,678,000 — 
Liability-classified awards— — 1,348,862 — 
Exercise of common stock options163,660 186,026 179,660 225,899 
Total anti-dilutive securities38,205,243 16,595,837 33,691,544 16,002,386